Operose Advisors’s iShares Morningstar Mid-Cap Growth ETF IMCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.8K Sell
659
-229
-26% -$20.7K 0.01% 280
2026
Q1
$69.9K Hold
888
0.02% 248
2025
Q4
$70.9K Hold
888
0.02% 250
2025
Q3
$73.5K Hold
888
0.02% 229
2025
Q2
$71.2K Hold
888
0.02% 203
2025
Q1
$63.4K Hold
888
0.02% 194
2024
Q4
$67.1K Hold
888
0.02% 192
2024
Q3
$64.8K Hold
888
0.02% 237
2024
Q2
$60.2K Hold
888
0.02% 221
2024
Q1
$62.8K Hold
888
0.02% 227
2023
Q4
$57.2K Hold
888
0.02% 209
2023
Q3
$50.7K Hold
888
0.02% 310
2023
Q2
$54.1K Hold
888
0.02% 159
2023
Q1
$51.1K Hold
888
0.03% 154
2022
Q4
$47.8K Hold
888
0.03% 157
2022
Q3
$45K Hold
888
0.03% 153
2022
Q2
$46K Hold
888
0.03% 145
2022
Q1
$57K Hold
888
0.04% 140
2021
Q4
$65K Buy
+888
New +$64.6K 0.05% 122

Other funds holding IMCG

Operose Advisors's IMCG Position: Q2 2026 in Review

Operose Advisors reduced its iShares Morningstar Mid-Cap Growth ETF (IMCG) stake by 26% in Q2 2026, selling an estimated $20.7K and leaving 659 shares worth $64.8K. The position accounts for 0.01% of the portfolio, ranked #280.

Operose Advisors first reported a position in IMCG in Q4 2021 and has held it in 19 quarters since. The position peaked at $73.5K in Q3 2025. 423 funds tracked by Wall St. Rank hold IMCG as of Q2 2026.

  • Operose Advisors held 659 shares of iShares Morningstar Mid-Cap Growth ETF worth $64.8K as of Q2 2026.
  • Operose Advisors sold 229 iShares Morningstar Mid-Cap Growth ETF shares in Q2 2026, an estimated $20.7K.
  • iShares Morningstar Mid-Cap Growth ETF made up 0.01% of Operose Advisors's portfolio in Q2 2026, its #280 holding.
  • Operose Advisors first reported a position in iShares Morningstar Mid-Cap Growth ETF in Q4 2021 and has held it in 19 quarters since.
  • Operose Advisors's iShares Morningstar Mid-Cap Growth ETF position peaked at $73.5K in Q3 2025.
  • 423 funds tracked by Wall St. Rank held iShares Morningstar Mid-Cap Growth ETF as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.